FAQ

Human vaccinia immune globulin

Known as: vaccinia immune globulin, vaccinia immunoglobulin 
 

Topic mentions per year

Topic mentions per year

1962-2015
02419622015

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
Progressive vaccinia: case description and laboratory-guided therapy with vaccinia immune globulin, ST-246, and CMX001.
Progressive vaccinia (PV) is a rare but potentially lethal complication that develops in smallpox vaccine recipients with… (More)
Is this relevant?
2011
2011
Postexposure prevention of progressive vaccinia in SCID mice treated with vaccinia immune globulin.
A recently reported case of progressive vaccinia (PV) in an immunocompromised patient has refocused attention on this condition… (More)
Is this relevant?
2011
2011
Capturing the natural diversity of the human antibody response against vaccinia virus.
The eradication of smallpox (variola) and the subsequent cessation of routine vaccination have left modern society vulnerable to… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2009
2009
Effective post-exposure protection against lethal orthopoxviruses infection by vaccinia immune globulin involves induction of adaptive immune response.
The therapeutic potential of human vaccinia immunoglobulin (VIG) in orthopoxvirus infection was examined using two mouse models… (More)
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 5
Is this relevant?
2009
2009
Smallpox vaccines induce antibodies to the immunomodulatory, secreted vaccinia virus complement control protein.
Vaccination with Dryvax elicits a broad humoral response against many viral proteins. Human vaccinia immune globulin was used to… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
2005
2005
Identification and preliminary characterization of vaccinia virus (Dryvax) antigens recognized by vaccinia immune globulin.
Using vaccinia immune globulin (VIG), a high-titer antibody preparation from immunized subjects, we demonstrate that the humoral… (More)
Is this relevant?
2005
2005
Biological activity of an intravenous preparation of human vaccinia immune globulin in mouse models of vaccinia virus infection.
The biological activity of a new intravenous (i.v.) preparation of human vaccinia immune globulin (VIGIV) was evaluated in two… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2004
2004
Safety and pharmacokinetic evaluation of intravenous vaccinia immune globulin in healthy volunteers.
BACKGROUND Vaccinia immune globulin (VIG) administered via the intramuscular route has historically been used for the treatment… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
Is this relevant?
Review
2004
Review
2004
Clinical efficacy of intramuscular vaccinia immune globulin: a literature review.
BACKGROUND Numerous literature reports describe clinical efficacy of intramuscular vaccinia immune globulin (VIG) for… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
1997
1997
Progressive vaccinia treated with ribavirin and vaccinia immune globulin.
A 67-year-old man with metastatic melanoma and chronic lymphocytic leukemia was inadvertently given a vaccinia melanoma… (More)
Is this relevant?